Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

Phase 3

Kowa Research Europe

Pitavastatin
Simvastatin